http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003109553-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6face648ea1753ab76b90b91c7c82e |
| publicationDate | 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003109553-A1 |
| titleOfInvention | Treatment of diabetes with thiazolidinedione and metformin |
| abstract | A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a mammal which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a biguanide antihyperglycaemic agent, to a mammal in need thereof and a pharmaceutical composition comprising an insulin sensitiser and a biguanide antihyperglycaemic agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004102486-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005136111-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007281023-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007275063-A1 |
| priorityDate | 1997-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 224.